324 results match your criteria: "Dr R. P. Centre for Ophthalmic Sciences[Affiliation]"
Indian J Ophthalmol
December 2024
Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Purpose: This study aims to assess the effectiveness of atropine 0.05% for myopia control among children exhibiting (documented) rapid myopia progression (>0.75D/year).
View Article and Find Full Text PDFIndian J Ophthalmol
January 2025
Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.
Purpose: The primary objective was to evaluate the clinical response of refractory cases of fungal keratitis to topical 1% posaconazole therapy.
Methods: Prospective longitudinal non-randomized open label dual-cohort study of 70 eyes of refractory fungal keratitis, 35 were recruited as posaconazole treatment (PCZ) group for topical 1% posaconazole therapy and compared to 35 eyes on conventional antifungal therapy. Study parameters included demographic and treatment details, visual acuity, comprehensive slit-lamp biomicroscopy, clinical photography, ASOCT at recruitment and weekly (week 1, 2, 3 and 4 after treatment initiation).
Indian J Ophthalmol
January 2025
Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Indian J Ophthalmol
December 2024
Chief, Dr. R P Centre for Ophthalmic Sciences, New Delhi, India.
Indian J Ophthalmol
December 2024
Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Sci Rep
November 2024
Ocular Pharmacology and Therapeutics Lab, Centre for Medical Biotechnology, Amity Institute of Biotechnology, Amity University Uttar Pradesh, Noida, 201313, India.
Reactive oxygen species (ROS) are essential for cancer signalling pathways and tumour maintenance, making ROS targeting a promising anti-cancer strategy. Coenzyme Q (CoQ10) has been shown to be effective against various cancers, but its impact on retinoblastoma, alone or with trolox, remains unreported. Cytotoxicity of CoQ alone and with trolox was evaluated in normal human retinal pigment epithelium cells (ARPE-19) and Y79 retinoblastoma cells using CCK-8.
View Article and Find Full Text PDFLab Invest
December 2024
Department of Ocular Pathology, Dr R.P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Delhi, India. Electronic address:
High pigmentation and the abundance of M2 macrophages have been identified as negative predictors in uveal melanoma (UM). Risk factors associated with UM that are prevalent in high-risk White populations are still present, although less common, in relatively low-risk Asian populations. Research indicates that proangiogenic M2 macrophages and monosomy 3 play significant roles in UM progression.
View Article and Find Full Text PDFIndian J Ophthalmol
November 2024
Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Indian J Ophthalmol
October 2024
Department of Ophthalmology, AIIMS, Bilaspur, Himachal Pradesh, India.
Indian J Ophthalmol
October 2024
Professor of Ophthalmology, Cornea and Ocular Surface, Cataract and Refractive Services, Dr R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Indian J Radiol Imaging
October 2024
Department of Hospital Administration, All India Institute of Medical Sciences New Delhi, New Delhi, India.
The Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act (PC&PNDT Act), 1994 was enacted to prevent sex determination and female feticide. As a mandatory statutory requirement, All India Institute of Medical Sciences, New Delhi, India has to renew its PC&PNDT license after every 5 years. The current study was undertaken with an objective to delineate in detail, the process of PC&PNDT license renewal, and the challenges dealt with while submitting the renewal application.
View Article and Find Full Text PDFMed J Armed Forces India
October 2022
Senior Resident (Oculoplasty, Tumor & Pediatric Ophthalmology Services), Dr R. P. Centre for Ophthalmic Sciences, AIIMS, New Delhi, India.
Med J Armed Forces India
August 2022
Professor (Ophthalmology), Faculty In Charge Unit 6 (Cornea, Cataract & Refractive Surgery, Ocular Oncology & Low Vision Services), Dr Rajendra Prasad Centre for Ophthalmic Sciences, AIIMS, New Delhi, India.
Indian J Ophthalmol
December 2024
Cornea, Ocular Surface, and Refractive Services, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Indian J Ophthalmol
September 2024
Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Natl Med J India
August 2024
Dr R.P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Indian J Ophthalmol
August 2024
Department of Vitreo Retina, Dr. R.P. Centre for Ophthalmic Sciences, New Delhi, India.
Context: Concerns about brolucizumab's (Pagenax®) association with intraocular inflammation (IOI) limit its use despite its cost-effectiveness and efficacy. This multicentric study analyzes IOI incidence across 21 tertiary eyecare centers in India since its introduction in October 2020.
Purpose: To determine the real-world incidence rate of IOI in Indian patients secondary to intravitreal brolucizumab across 21 tertiary eye care centers in India.
Indian J Ophthalmol
August 2024
Cornea, Cataract and Refractive Surgery Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Science, New Delhi, India.
Indian J Ophthalmol
August 2024
Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Natl Med J India
June 2024
Dr R.P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Indian J Ophthalmol
July 2024
Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Ophthalmol Retina
December 2024
Department of Ophthalmology, Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Delhi, India.
Ocul Immunol Inflamm
December 2024
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Indian J Ophthalmol
June 2024
Cornea and Ocular Surface, Cataract and Refractive Services, Dr. R P Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Indian J Ophthalmol
May 2024
Dr. R. P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.